Clarivate PLC: Q2 2025 Financial Summary
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended June 30, 2025. Clarivate PLC is a global provider of transformative intelligence serving the Academia & Government (A&G), Intellectual Property (IP), and Life Sciences & Healthcare (LS&H) markets. The company operates primarily through subscription-based and re-occurring revenue models.
Key Financial Metrics (Six Months Ended June 30, 2025)
| Metric | Value (in millions) |
|---|---|
| Revenues | $1,215.1 |
| Net Loss | $(175.9) |
| Adjusted EBITDA | $494.8 |
| Adjusted EBITDA Margin | 40.7% |
| Operating Cash Flow | $287.5 |
| Free Cash Flow | $160.6 |
| Total Debt Outstanding | $4,570.5 |
| Cash and Cash Equivalents | $362.6 |
| Share Repurchases (YTD) | $99.5 |
Material Changes vs. Prior Period
- Revenue Decline: Revenues decreased 4.4% year-over-year (YoY) to $1,215.1 million. This was driven by disposals (ScholarOne and Valipat divestitures) and product group wind-downs, which offset organic growth of 0.4%.
- Profitability Improvement: Net loss narrowed significantly to $(175.9) million from $(379.3) million in the prior year. This improvement is largely due to the absence of a $302.8 million goodwill impairment charge recorded in Q2 2024.
- Restructuring Costs: Restructuring and other impairments increased to $34.0 million (vs. $10.2 million prior year), primarily due to the "Value Creation Plan" initiated in late 2024.
- Foreign Exchange Impact: Other operating expenses increased due to net foreign exchange losses of $53.4 million, primarily driven by GBP transactions.
- Debt Refinancing: In May 2025, the company issued $500.0 million in new term loans to redeem an equal amount of Senior Secured Notes due 2026, extending the debt maturity profile.
Guidance, Outlook, and Risks
- Value Creation Plan: Management expects to incur approximately $5 million in additional restructuring costs, primarily from workforce reductions, with the majority expected in 2025.
- Organic Growth: Organic Annualized Contract Value (ACV) grew 1.3% compared to the prior year, driven by price increases. Total ACV declined 3.5% due to divestitures and wind-downs.
- Renewal Rates: The annual renewal rate for the six months ended June 30, 2025, was 93%, up from 92% in the prior year.
- Tax Legislation: The "One Big Beautiful Bill Act" (OBBBA) was enacted on July 4, 2025. The company is currently assessing the impact on its consolidated financial statements; it is not reflected in the Q2 results.
- Risks: Key risks include dependence on third-party data, competition from free information sources, cybersecurity threats, and the impact of global minimum tax (Pillar Two) regulations.
Investor Verification Checklist
- Verify the sustainability of organic revenue growth (0.4% YTD) amidst ongoing product group wind-downs.
- Monitor the execution and cost savings realization of the "Value Creation Plan" restructuring initiative.
- Assess the impact of the new $500 million term loan and associated interest rate hedging on future interest expense.
- Review the status of pending securities class action litigation regarding prior accounting errors and internal controls.
- Confirm the final tax impact of the OBBBA legislation in the upcoming Q3 filing.